NUCLEOME

What this means for you

Not registered yet, but its 13 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79422826

Mark type

Stylized text

Filed

13 Feb 2025

Attorney of record

Rebecca Liebowitz

Goods and services

• Class 001 — Chemicals: Reagents for research use, other than for medical and veterinary purposes; chemical diagnostic reagents for industrial purposes, other than for medical and veterinary purposes; diagnostic reagents, other than for medical and veterinary purposes; kits for research, industry and diagnostic purposes, comprised of industrial chemicals, reagents for research use and diagnostic preparations for scientific use other than for medical and veterinary purposes; reagents for medical research; kits for medical research comprised of reagents for research use, diagnostic preparations for scientific use; biological preparations for use in industry and science; diagnostic biological preparations for research laboratory use; human cells and isogenic cell lines for research and scientific purposes, not for medical and veterinary use
• Class 009 — Scientific and electric apparatus: Downloadable and recorded computer database management software; downloadable and recorded computer software for data analysis and reporting of clinical research results, medical patient test results; downloadable and recorded computer software for the sequencing, annotation, analysis, interpretation and reporting of genome data; downloadable and recorded computer software for potential patient identification and potential patient stratification; downloadable and recorded computer software for medical diagnosis of inflammatory diseases; downloadable and recorded computer software for drug discovery and research; downloadable and recorded computer software for research of information for development of therapeutics to treat diseases; downloadable and recorded computer software for analysis of data relating to pharmaceutical development; downloadable and recorded computer databases in the field of medical data and scientific data; computer database servers; computer software for database management; downloadable and recorded computer software for creating searchable databases of information and data
• Class 042 — Scientific and technological services: Research and development services in the field of immunology; scientific research and development services; biotechnology research and development services; pharmaceutical research and development services; drug discovery; pharmaceutical drug development; research and development services in the field of genomics; structural and functional analysis of genomes; research and development services in the field of bioinformatics; research and development of personalised medicine; research and development of precision medicine; research and development of stratified medicine; research and development in the field of drug discovery; research and development in the field of drug target discovery; scientific research and development services in the field of clinical trial design for others; research and development services in the field of medical diagnostics preparations; research and development of pharmaceuticals and pharmaceutical compounds; research and development of pharmaceutical preparations and medicines; research and development of medicines; medical preparation research and development services; research related to genomics, bioinformatics, personalised medicine, precision medicine, drug discovery; design and development of databases; design and development of computer software; design and development of computer databases; database design and development services; computer database design and development services; design and development of computer software used for services in the field of pharmaceuticals, clinical trials, personalised medicine and genetics; design and development of computer database used for services in the field of pharmaceuticals, clinical trials, personalised medicine and genetics; genome interpretation services being structural and functional analysis of genomes; software as a service (SAAS) services featuring software for genome sequencing, annotation, interpretation and reporting; providing an online searchable database in the field of genome sequencing, annotation, interpretation, and reporting for scientific research purposes; software as a service (SAAS) services featuring software for drug discovery and research; providing an online searchable database in the field of drug discovery and research for scientific research purposes; software as a service (SAAS) services featuring software for potential patient identification and potential patient stratification; providing software as a service (SAAS) services featuring software for medical diagnosis of inflammatory diseases; providing an online searchable database in the field of potential patient identification, potential patient stratification, and medical diagnosis, for scientific research purposes; software as a service (SAAS) services featuring software for research of information, for development of therapeutics to treat diseases, for collecting, analyzing, and organizing data in the field of immunology; providing an online searchable database in the field of immunology for medical research purposes; information, advisory and consultancy services in relation to all of the aforesaid; cell-line engineering services; gene editing services for scientific research purposes; consultancy, advisory and information services relating to the aforementioned services
• Class 044 — Medical, beauty and agricultural services: Analysis of data for medical and health purposes, namely, medical analysis for the diagnosis and treatment of persons; providing medical and health information and advice relating to genetics and pharmaceuticals; providing data being medical and health information relating to genetics and pharmaceuticals; pharmaceutical services, namely, pharmaceutical consultation, pharmaceutical compounding services; medical and healthcare services relating to DNA, genetics and genetic testing; providing an online computer database featuring information regarding health; consultancy, advisory and information services relating to the aforementioned services

Owner

• Nucleome Therapeutics Limited, GB

Prosecution history

• 18 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 18 Mar 2026 — NON-FINAL ACTION E-MAILED
• 18 Mar 2026 — NON-FINAL ACTION WRITTEN
• 27 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 27 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 27 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 19 Sept 2025 — REFUSAL PROCESSED BY IB
• 30 Aug 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 29 Aug 2025 — REFUSAL PROCESSED BY MPU
• 25 Jul 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 24 Jul 2025 — NON-FINAL ACTION WRITTEN
• 21 Jul 2025 — ASSIGNED TO EXAMINER
• 02 May 2025 — APPLICATION FILING RECEIPT MAILED
• 02 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
• 01 May 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB